Statin-intolerant, ASCVD secondary prevention

Lerodalcibep (Lerochol)

Outcome

Well tolerated & effective

Would recommend

Yes

Dose

Once a month

Payer

Out-of-pocket/cash

Coverage

N/A-paid cash

Price

USD 199/mo

Side effects

Injection site reaction

A little redness at the shot site for a day. Otherwise nothing.

Their story

After my heart attack I couldn't stay on statins because of muscle pain. My plan denied Repatha even with the paperwork from my cardiologist. I switched to Lerochol through the direct cash program while my appeal sat in limbo. The monthly shot has been easy.

Their story

Atorvastatin · Apr 2024 to Jul 2024 · Stopped-side effects
Evolocumab (Repatha) · Aug 2024 to Aug 2024 · Stopped-cost
Lerodalcibep (Lerochol) · Jan 2026 to now · Well tolerated & effective

LDL (mg/dL)apoB (mg/dL)

1654812252

20252026

All lab values

Date	Total chol	LDL	Non-HDL	HDL	Trig	Lp(a)	ApoB
2024-03-15	240	165	198	42	160	-	122
2026-04-15	120	48	76	44	140	-	52

Topics:Statin intolerance PCSK9 denied Lerochol

Follow-up

Seven months on the monthly shot. The cash program price hasn't changed and my last LDL was under 50.

Comments

Share experiences and logistics (pharmacy, cost, coupons), not medical advice. For decisions about your treatment, talk to your clinician.

No comments yet.